Sitagliptin-Metformin-Mepha cpr pell 50/850mg, , Sitagliptin-Metformin-Mepha cpr pell 50/850mg blist 196 pce (ancien)
7680683780043
CH-68378
A10BD07
1 / 3
google
Details
- Product number
- 6837802
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Sitagliptin-Metformin-Mepha 50/850 mg, Filmtabletten
Filmtabletten
196
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
metformini hydrochloridum
|
850.0 MG | Substance | Wirkstoff (Principe actif) |
|
sitagliptinum
|
50.0 MG | Substance | Wirkstoff (Principe actif) |
|
sitagliptini hydrochloridum monohydricum
|
- | Substance | WIZUS |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
povidonum K 29-32
|
- | Substance | HNIDK |
|
natrii laurilsulfas
|
- | Substance | Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration) |
|
magnesii stearas
|
- | Substance | HNIDK |
|
copolymerum macrogolo et alcoholi poly(vinylico) constatum
|
- | Substance | HNIDK |
|
talcum
|
- | Substance | HNIDK |
|
glyceroli mono/dicaprylocapras
|
- | Substance | HNIDK |
|
poly(alcohol vinylicus)
|
- | Substance | HNIDK |
|
E 171
|
- | Substance | FNIDK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
|
natrium
|
0.441 MG | Substance | HBESI |
Reimbursement information
Public price
CHF 52.60
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/05/2023
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 68378
- Drug name
- Sitagliptin-Metformin-Mepha, Filmtabletten
- Galenic form
- FILM
- ATC Code
- A10BD07
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 05/04/2022
- Authorization expiration date
- 31/12/9999
- IT number
- 07.06.2.
- Domain
- Human medicine
Packaging details
- Description (FR)
- SITAGLIPTIN Metformin Mepha 50/850mg 196 pce
- Description (DE)
- SITAGLIPTIN Metformin Mepha 50/850mg 196 Stk
- Market launch
- 05/04/2022
- Market withdrawal
- 01/09/2026
- Narcotic (BTM)
- No